cellular
N |
• cell cycle and cell growth parameters of mouse embryo fibroblasts (MEFs)
• DNA damage response (DDR) of MEFs to gamma-irradiation or radiomimetic drugs hydroxyurea and camptothecin
|
• sensitive to replicative stress caused by low doses (0.1-0.4 mM) of hydroxyurea: significantly lower survival rate of treated MEFs compared to similarly treated wild-ty
• DNA damage response (DDR) of mouse embryo fibroblasts (MEFs) to high dose (5 mM) of radiomimetic drug hydroxyurea
|
embryo
N |
• no obvious phenotype regarding embryonic development; mice born in expected Mendelian ratios
|
endocrine/exocrine glands
• in some mice after neonatal infection with Moloney murine leukemia virus MOL4070A
|
growth/size/body
N |
• no obvious phenotype regarding postnatal growth
|
• after neonatal infection with Moloney murine leukemia virus MOL4070A
|
hematopoietic system
• in some mice after neonatal infection with Moloney murine leukemia virus MOL4070A
|
• after neonatal infection with Moloney murine leukemia virus MOL4070A
|
immune system
• in some mice after neonatal infection with Moloney murine leukemia virus MOL4070A
|
• after neonatal infection with Moloney murine leukemia virus MOL4070A
|
• in some mice after neonatal infection with Moloney murine leukemia virus MOL4070A
|
neoplasm
• after neonatal infection with Moloney murine leukemia virus MOL4070A
• increased acute lymphoblastic leukemia (ALL) incidence in 7 of 10 mice
• increased acute myeloid leukemia (AML) incidence in 1 of 10 mice
• all mice develop leukemia within 1 year
• leukemic cells proliferated in peripheral blood and infiltrated liver, spleen, lymph nodes and other tissues
• acute undifferentiated leukemia (AUL) incidence in 1 of 10 mice
|